Zuzanna Fimińska

Zuzanna Fimińska

Zuzanna Fimińska's picture

Latest posts from :

Access and Evidence

Pharma Determined to Change Its...

Sep 17, 2015

Pharma's poor image is making it difficult to readily enter into fruitful...

Clinical

Personalized Medicine Ultimate...

Sep 14, 2015

Customized treatments are the final step in putting patients at the center of...

Clinical

Engaging Patients in Research

May 12, 2015

Web-based portals, social media, and connected devices offer an opportunity to...

Commercial

People Power: Can Crowdfunding...

May 11, 2015

As budgets shrink, crowdfunding offers an opportunity to derisk investment.

Commercial

Openness and Transparency Key

Apr 24, 2015

Problems begin when transparency and communication fail says EFPIA's Andie...

Access and Evidence

Real World Evidence: Supporting...

Apr 16, 2015

How can pharma use observational data to support discovery, research &...

Pharma’s Future Depends on...

Apr 16, 2015

We look at an adherence toolbox, which allows patients and HCPs to achieve...

Clinical

4 Ways to Guarantee your Trials...

Apr 16, 2015

Could trials be at risk of being invalidated by rebellion from patients?

Clinical

Alzheimer’s: Can we save the...

Apr 2, 2015

Alzheimer’s disease is a ticking time bomb for public health around the...

Nigel Hughes, Global Director, Marketing & Health Information Technology, Janssen Diagnostics

Access and Evidence, Clinical

Real World Evidence: Maximize...

Feb 26, 2015

With a staggering cost of drug development estimated at US$2.6 billion and a...

Pages